Doki, Yuichiro ;
Ajani, Jaffer A ;
Kato, Ken...
Doki , Y , Ajani , J A , Kato , K , Xu , J , Wyrwicz , L , Motoyama , S , Ogata , T , Kawakami , H , Hsu , C H , Adenis , A , El Hajbi , F , Di Bartolomeo , M , Braghiroli , M I , Holtved , E , Ostoich , S A , Kim , H R , Ueno , M , Mansoor , W , Yang , W C , Liu , T , Bridgewater , J , Makino , T , Xynos , I , Liu , X , Lei , M , Kondo , K , Patel , A , Gricar , J , Chau , I , Kitagawa , Y & CheckMate 648 Trial Investigators 2022 , ' Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma ' , The New England Journal of Medicine , vol. 386 , no. 5 , pp. 449-462 . https://doi.org/10.1056/NEJMoa2111380.
,
2022